KEYMED BIOSCIENCES INC financial statements, including revenue, expenses, profit, and loss
The total revenue of 2162 for the last semiannual is 29.14 M HKD, and it's 92.12% lower compared to the previous semiannual. The net income of H2 23 is -438.97 M HKD.